echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > The world's first human challenge trial of the new coronavirus has been approved

    The world's first human challenge trial of the new coronavirus has been approved

    • Last Update: 2021-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A number of foreign media reported that the British government issued a statement on the 17th local time, the country's clinical trial ethics agency has approved a new coronavirus human trial, 90 adult volunteers exposed to the new coronavirus environment, this is the world's first approved new coronavirus "human challenge test."
    is understood the trial will recruit 90 adult volunteers between the ages of 18 and 30 who have no previous history or symptoms of new coronary disease, no potential health conditions and a known adverse risk of contracting the new coronavirus, such as heart disease, diabetes or obesity The volunteers will be exposed to the new coronavirus in specialized isolation facilities to help researchers understand how the body responds to the virus, how it spreads, the minimum number of viruses needed to cause infection, and so on, thus accelerating the understanding of the new corona vaccine, treatment methods, and the trial is expected to start within a month.
    Also, before conducting the trial, volunteers must pass a health risk test and undergo a 17-day quarantine before they can participate in the challenge trial, during which they are closely monitored by experts and health care workers, and the volunteers undergo two new coronavirus tests after completing the trial, and only volunteers who have both negative results can leave the test site.
    more than 12 months of follow-up after the trial ended, and the volunteers were not paid, but would be compensated about 4,500 pounds (about 40,000 yuan).
    the trial, which was funded by the UK government for 33.6 million pounds ($300 million), was carried out by Imperial College London, the UK government's vaccine task force and clinical trial research firm hVIVO.
    The Human Challenge Trials" help clinical researchers determine which vaccines are most likely to succeed, and allow scientists to compare the efficacy of candidate vaccines by side-by-side testing to determine which ones are more effective, according to Imperial College London.
    "Our top priority is to keep volunteers safe, and my team has safely conducted more than 10 years of human challenge studies using other respiratory viruses, none of which are completely risk-free, but partners in the Human Challenge Project work to ensure that risk is minimized.
    ," says Chris Chiu, professor of infectious diseases at Imperial College London. Peter Openshaw, co-investigator of the
    Human Challenge Trials and director of the Human Challenge Alliance at Imperial College London, said: "Volunteers who deliberately infect healthy people with known human pathogens are by no means indispication, and such studies are undoubtedly of great help in identifying the mechanisms of a disease, even those that have been studied so much.
    " Although in order to better understand the new crown, the study has caused great controversy, the Washington Post reported on the 17th, let healthy people infected with a potentially deadly virus, even in a controlled environment is really necessary? In response, the head of the UK's vaccine working group said: "The UK has some safe and effective vaccines, but it is vital that we continue to develop new vaccines and treatments for the new coronavirus.
    "considering that high doses of the virus can lead to serious consequences, the researchers said they would infect volunteers at the 1st possible dose, triggering virus replication with reduced symptoms."
    To date, there have been nearly 110 million confirmed cases of new crown pneumonia and more than 2.43 million deaths worldwide, of which more than 27 million have been confirmed in the United States and 490,540 have died, according to real-time data on global outbreaks at Johns Hopkins University in the United States. India was followed by India with 10950201 confirmed cases and 156,014 deaths, followed by Brazil with 997,8747 confirmed cases, followed by the United Kingdom with 408,3092 confirmed cases and more than 110,000 deaths.
    source: Medical Valley.com Copyright Notice: All text, images and audio and video materials that indicate "Source: Mets Medicine" or "Source: MedSci Originals" on this website are owned by Mets Medical and may not be reproduced by any media, website or individual without authorization, and shall be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.